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Background: High serum triglyceride (TG) levels is an established risk factor for coronary heart disease (CHD). Fat is
stored in the form of TGs in human adipose tissue. We hypothesized that gene co-expression networks in human
adipose tissue may be correlated with serum TG levels and help reveal novel genes involved in TG regulation.
Methods: Gene co-expression networks were constructed from two Finnish and one Mexican study sample using
the blockwiseModules R function in Weighted Gene Co-expression Network Analysis (WGCNA). Overlap between
TG-associated networks from each of the three study samples were calculated using a Fisher’s Exact test. Gene
ontology was used to determine known pathways enriched in each TG-associated network.
Results: We measured gene expression in adipose samples from two Finnish and one Mexican study sample. In
each study sample, we observed a gene co-expression network that was significantly associated with serum TG
levels. The TG modules observed in Finns and Mexicans significantly overlapped and shared 34 genes. Seven of the
34 genes (ARHGAP30, CCR1, CXCL16, FERMT3, HCST, RNASET2, SELPG) were identified as the key hub genes of all three
TG modules. Furthermore, two of the 34 genes (ARHGAP9, LST1) reside in previous TG GWAS regions, suggesting
them as the regional candidates underlying the GWAS signals.
Conclusions: This study presents a novel adipose gene co-expression network with 34 genes significantly
correlated with serum TG across populations.
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Coronary heart disease (CHD) is the most common
cause of death in the Western world. Serum triglyceride
(TG) levels have been implicated as a well known risk
factor for CHD [1]. Genome-wide association studies
(GWAS) have been successful in identifying common
variants and candidate genes influencing serum TG
levels. A recent metaGWAS found, however, that the
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reproduction in any medium, provided the orvariation in TG levels [2], leaving a large portion of pre-
dicted genetic heritability of TGs (35%-48%) [3] undis-
covered. Additionally, GWAS often have association
signals spanning many genes, which results in several
potential gene candidates that cannot be narrowed down
using GWAS alone. The Mexican population has a high
risk of dyslipidemia, with 31.5% of the population suffer-
ing from hypertriglyceridemia (TGs>1.7 mmol/l) [4].
Additionally, no genome-wide transcriptome analysis
for lipids to date has been performed in Mexicans. Thus,
exploring adipose tissue gene co-expression networks
in Mexicans is necessary to better understand lipid
regulation in this underinvestigated population. The
Finnish population represents a genetically relativelyd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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heterogeneity in the statistical analysis [5]. Adipose tis-
sue is a key player in CHD progression through influen-
cing systemic inflammation, insulin resistance, and
serum TG levels [6]. In this study, we investigated
whether serum fasting TG levels are related to adipose
co-expression networks in human. Although synthesis of
TGs occurs not only in adipose tissue but also in other
tissues such as liver, hydrolysis of TGs, lipolysis, occurs
predominantly in adipose tissue [7]. During fasting, adi-
pose tissue hydrolyzes stored TGs and releases glycerol
and fatty acids into the bloodstream. Previous studies
have shown that excess TG hydrolysis in adipose tissue
is associated with insulin resistance and can cause ec-
topic TG storage and high serum fatty acid levels [7].
Another relevant tissue for lipid metabolism is liver.
However, obtaining liver biopsies from living study sub-
jects for research purposes is complicated by the risks
related to the procedure, making the adipose tissue a
more accessible tissue than liver in humans. Previous
studies have analyzed gene expression data from sub-
cutaneous adipose tissue to search for genes involved in
one of adipose tissue’s several functions [8-10]. However,
to the best of our knowledge, no prior study has focused
on discovering underlying lipid co-expression networks
in adipose tissue shared across multiple populations.
Weighted Gene Co-expression Network Analysis
(WGCNA) is a well-established tool that identifies novel
gene co-expression networks and searches for associa-
tions between a network and a phenotypic trait [10-14].
Determining novel genes and adipose networks corre-
lated with serum TG levels consistently across popula-
tions helps lay the foundation for future functional
studies to uncover the underlying mechanisms. We
hypothesized that searching for TG-associated adipose
networks preserved across populations may reveal novel
genes involved in TG regulation. Comparing TG-
associated gene expression networks from WGCNA in
three independent sets of samples from adipose tissue of
two different populations is a unique approach to disco-
vering novel TG genes. The fact that the genes we dis-
covered were members of TG modules in all three
independent sets of samples and replicated across two
populations provides strong evidence that the TG genes
identified are genuine signals of biological importance.
Results
Weighted gene co-expression network analysis (WGCNA)
To search for novel gene co-expression networks
involved in adipose TG regulation, we performed a gene
co-expression network analysis using WGCNA [11,12]
in 53 adipose RNAs from Finnish twins. The clinical
characteristics of the twin study sample, including mean
lipid values are shown in Additional file 1. To correctfor the relatedness of the monozygotic twins, gene ex-
pression values were corrected for kinship (see meth-
ods). WGCNA identifies gene co-expression networks
(modules), summarizing the main patterns of variation.
Modules can be related to traits and sequence variants.
The first principal component represents the summary
of the module and is referred to as the module eigen-
gene (ME) [11,12]. ME is the average module expression
value for an individual. Relating MEs instead of genes to
a clinical trait is a major advantage of WGCNA as it
diminishes the multiple testing from thousands of tran-
scripts to the number of modules. Thus, instead of test-
ing correlation between every transcript and a trait, we
only test the correlation between the ME value and the
trait. We used two key metabolic traits to search for
module-trait correlations in human adipose tissue:
serum TGs and BMI. The two traits were tested as
quantitative traits (by adjusting and not adjusting for
covariates, see methods). We observed seven modules in
the Finnish twins of which the blue module was posi-
tively correlated with serum TGs (P=5x10-4, Figure 1),
indicating that TGs are higher in individuals with high
ME values. The adjusted TG levels provided similar
results (Figure 1). Figure 1 shows that the most signifi-
cant TG modules were also implicated for BMI. It is
worth noting that in WGCNA the grey module always
represents background genes outside of modules, i.e.
genes that cannot be clustered into one of the modules
are assigned to the grey module. Thus, the grey module
may contain genes that are associated with TGs but are
not part of a WGCNA module.
WGCNA TG modules preserved across populations
To test whether the TG-associated co-expression net-
works observed in a European origin population can
be replicated in another population, we investigated
whether the Finnish twin TG module is preserved in
70 Mexican TG case/control fat biopsy samples [10].
The clinical characteristics of the Mexican study
sample, including mean lipid values are shown in
Additional file 1. Mexican population represents an
admixed population of European, Amerindian and African
origin [15]. Figure 2 illustrates that the Finnish twin TG
module is highly preserved in the Mexicans (Z score ~ 30).
A preservation Z score >10 is considered significant
preservation (see methods). Furthermore, the entire
structure of adipose gene expression networks observed
in the Finns was preserved in Mexicans, as all Finnish
network modules had Z scores>10 (Figure 2). Given the
observed significant module preservation between the
Finns and Mexicans, we hypothesized that many of the
genes detected in the Finnish TG network module could
be replicated in Mexicans. In the WGCNA analysis of
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Figure 1 Finnish twin WGCNA results indicate that the blue
module is associated with serum TG levels. Each row represents
a module (labeled by color), and each column represents a trait. The
value at the top of each square represents the correlation coefficient
between the module eigengene and the trait with the correlation p-
value in parentheses. The red color represents a positive correlation
between the module eigengene and trait, and the green color
represents a negative correlation. The number of gene expression
probes present in each module and the percent of probes
correlated with TGs (p<0.05, Pearson correlation) are listed in
parenthesis next to the module color. To prevent potential
confounding factors influencing expression values, gene expression
values were corrected for age, sex, and twin relatedness using the
Microarray Quality Control Pipeline as described previously [10]. TG
values were log transformed and corrected for age, sex,
disconcordant BMI status, and BMI using stepwise linear regression.
BMI values were corrected for age, sex, disconcordant BMI status,
and TG using stepwise linear regression. Genes that could not be
clustered into one of the modules were assigned to the grey
module, thus grey denotes background genes outside of modules.
The blue module associated with TGs passed the Bonferroni
correction for the 16 statistical tests performed (8 modules, 2 traits);
the Bonferroni p-value cut-off = 3.1 x 10-3.
Figure 2 Finnish twin WGCNA blue TG module is preserved in
Mexican TG cases/controls. Each data point represents a Finnish
twin WGCNA module. A Zsummary value over 2 represents a
moderately preserved module. A Zsummary value over 10 provides
strong evidence of module preservation. To prevent potential
confounding factors influencing expression values, Finnish twin
gene expression values were corrected for age, sex, and twin
relatedness using the Microarray Quality Control Pipeline as
described previously [10].
Figure 3 Genes in the Finnish and Mexican TG modules
significantly overlap. The blue square represents Finnish TG
module genes (n=320), and the pink square represents Mexican TG
modules genes (n=123) determined by WGCNA. Area represented is
proportional to the number of genes present in each group. P-value
was calculated using a Fisher’s Exact test.
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associated with serum TGs (P=1.0 x 10-4, Additional file 2).
It is worth noting that as the color labels for WGCNA are
given based on the number of probes found in the
given module, module colors in different sets of sam-
ples are not comparable and thus, comparing the
color labels observed between the sets of samples
does not indicate whether the modules are related.
Importantly, 115 of the 123 genes in the yellow
Mexican TG module were shared between the
Finnish and Mexican TG modules, and thus 93.5% of
the TG module genes in Mexicans overlapped with
the Finns (P=1.98 x 10-160 for the overlap, Figure 3).
We also investigated the module membership of the
genes shared between the Mexican and Finnish TGmodules. The module membership of a gene is defined
as the correlation coefficient of its expression profile
and the corresponding module eigengene across sam-
ples (see methods). We observed that the module
memberships of the genes shared between the Mexican
and Finnish TG modules are highly correlated (r=0.67,
p=1.56x10-16), providing additional evidence that the
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conserved between the Mexican and Finnish sets of
samples, because in both populations the genes have
similar degrees of relatedness to the TG module.
To search for enrichments in biological gene ontology
(GO) functions linking the Finnish and Mexican TG
modules to adipose TG regulation, we utilized the
DAVID database [16,17]. We observed five significantly
enriched (Bonferroni corrected P<0.001) gene ontology
(GO) biological process terms present in both the
Finnish and Mexican modules, all including immunity
and inflammation categories (Table 1). Taken together,
these data provide novel evidence that the gene expres-
sion signatures in human adipose tissue are correlated
with serum TG levels in a highly similar way across dif-
ferent populations. To further establish the robustness
of the gene sets found in the Finnish and Mexican TG
modules, we performed WGCNA in a third sample, adi-
pose RNAs from 20 Finnish METSIM TG cases/controls
that were analyzed using a different gene expression ap-
proach, RNAseq. The clinical characteristics of the
METSIM study sample, including mean lipid values are
shown in Additional file 1. This comparison of the Affy-
metrix microarray and RNAseq data should decrease the
well-known variability and errors in the measurement
methods of gene expression. We observed that the
brown module in the METSIM TG case/control sample
was significantly associated with TG levels (P=2.0 x 10-4,
Additional file 3). Furthermore, the Finnish twin TG
module was the most preserved module in the METSIM
TG case/controls (Additional file 4). Importantly, 34 of
the 115 genes shared between the Finnish twins and
Mexicans overlapped with the Finnish METSIM TG
module (P<10-10 for the overlap). We focused our subse-
quent studies on these 34 genes as they represent the
significant overlap robustly observed across populations
and different gene expression approaches. It is also
worth noting that the TG trait provided a significantly
associated network module passing Bonferroni correc-
tion for the two tested traits and the number of modules
in all three sets of samples whereas no such consistent
network was observed for BMI (Figure 1, Additional filesTable 1 Gene ontology categories enriched in both Mexican a
Finnish twins
Gene Ontology Biological Process Bonferroni
Defense Response 3.06 × 10-11
Immune Response 2.42 × 10-9
Inflammatory Response 2.29 × 10-5
Response to Wounding 4.17 × 10-5
Positive Regulation of Immune Response 4.25 × 10-2
All p-values were corrected for multiple testing using the Bonferroni correction. The
were obtained using the GO_BP_FAT category of the DAVID bioinformatics databas2, 3). Furthermore, when we looked into the percentages
of genes correlated versus not correlated with TGs in all
network modules throughout the three sets of samples,
we observed that the TG-associated network modules in
each of the three sets of samples (i.e. the blue module in
the Finnish twins, the yellow module in the Mexicans
and the brown module in the METSIM TG case/control
sample) contain the highest percentages of genes corre-
lated with TGs (Figure 1, Additional files 2, 3). All of the
WGCNA network analyses identifying the 34 genes were
performed using quantitative TG values. To investigate
whether the across populations overlap was robust to
the analytical approach, we also investigated TGs as a
binary trait by classifying the subjects to high and low
TG groups (see methods) in the conventional differential
gene expression analysis. Using this qualitative TG ap-
proach, we discovered that the sets of samples also show
a significant overlap in the genes that are differentially
expressed between the high and low TG groups. Table 2
illustrates that the genes that are most differentially
expressed between the TG extremes are shared between
the sets of samples. Of the 37 genes common to all 3
top 500 differentially expressed gene lists, nine are also
part of all three TG modules (P<10-7 for the overlap). Of
the nine genes shared between these two lists, five lie
within 500kb of a suggestive TG GWAS signal (p<10-3)
[2], providing additional evidence that these genes are
involved in TG regulation. The observation that the
WGCNA TG module genes significantly overlap with
conventional differential gene expression analysis pro-
vides additional evidence that the TG regulatory genes
observed using the GO functional enrichment analysis
in human adipose tissue are highly shared across Finns
and Mexicans.
To search for a GO functional enrichment in which
the 34 genes are involved, we utilized the DAVID data-
base. The top four GO biological process categories
observed between the Finnish twins and Mexicans
(Table 1) were also significantly enriched among the 34
genes shared by all three sets of samples (Additional file 5).
To identify hub genes that may be driving the three TG
network modules, we searched for genes with high modulend Finnish twin TG modules
Mexican
# probes Bonferroni # probes
46 7.82 × 10-18 34
46 1.82 × 10-18 36
27 9.09 × 10-10 21
36 1.35 × 10-8 25
14 6.54 × 10-4 11
Gene Ontology biological process categories and the corresponding p-values
e [16,17].
Table 2 The most differentially expressed genes using conventional gene expression analysis overlap between the
three studies
p-values
Group Top 100 Genes* Top 250 Genes Top 500 Genes
Finnish Twins, Mexicans 2.81 × 10-33 2.01 × 10-69 6.51 × 10-103
METSIM, Finnish Twins 3.27 × 10-6 5.96 × 10-7 5.22 × 10-10
METSIM, Mexicans 2.11 × 10-4 2.48 × 10-5 2.24 × 10-8
*Genes were sorted in descending order by the difference in the average normalized gene expression values between the high and low TG groups. The overlap
p-values were calculated using a two-tail Fisher’s exact test. All p-values pass the Bonferroni correction for the nine statistical tests performed (p-value<5.6 x 10-3).
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and the module eigengene [the average module expression
value for an individual]) in all three TG modules. We found
seven genes (ARHGAP30, CCR1, CXCL16, FERMT3, HCST,
RNASET2, SELPG) among the 34 shared genes that had
significantly high module membership values in the top
50% in all three TG modules (P<10-7 for the overlap,
Table 3), and that are thus driving the three TG modules.
Two of these seven genes (CCR1 and CXCL16) have previ-
ously been implicated in type 2 diabetes, CHD, or inflam-
mation (Additional file 6). To determine whether any
of the known genes of adipose TG regulation are cor-
related with the three TG modules, we investigated
correlations of these positive control genes/gene fam-
ilies (MGAT family, DGAT family, and LPL), and
observed that expression of all 4 MGAT genes tested
(MGAT1, MGAT2, MGAT4A, MGAT4B) were significantly
correlated (P<0.05) with TG module kME (i.e. the correl-
ation between a gene expression value and the module
eigengene [the average module expression value for an
individual], see methods) in two or more of the sets of
samples, although they were not placed into the module
using WGCNA. It is worth noting that modules are
formed based on similar gene expression patterns across
multiple samples, so TG-associated genes that do not
exhibit highly correlated gene expression will be found
in different modules, and the grey module will contain
genes associated with TGs not belonging to a WGCNA
module. MGAT2 and MGAT4B were also correlated
(P<0.05) with serum TG values in at least two of the
sets of samples. These data support the biological rele-
vance of the new TG modules shared across three sets
of samples and two populations.Table 3 Genes with high module membership in the Finnish t
3 Triglyceride module overlap Gene(s)
1 gene with module membership* > 0.9 CCR1
2 genes in top 50 module membership HCST, FERMT3
3 genes in top 25% module membership CCR1, CXCL16, HCS
7 genes in top 50% module membership CCR1, CXCL16, HCS
*Module membership indicates the correlation coefficient between the module eig
The triglyceride modules referenced above are the brown METSIM module, the blu
calculated empirically by randomly selecting the observed number of genes satisfyi
occurring by chance.Investigation of common SNPs near TG module genes
and TG GWAS signals
To determine whether any significant TG GWAS SNPs
[2] may be acting through any of the 34 genes, we
explored regions harboring significant TG GWAS var-
iants around the 34 genes (±500 kb). We found that
both ARHGAP9 and LST1 lie near a genome-wide sig-
nificant TG GWAS signal2 (Additional files 7, 8), and
seven other TG module genes shared between the 3 sets
of samples (CD52, CXCL16, HCST, MS4A7, NCKAP1L,
PTPN6, and SPP1) lie within 500kb of a suggestive TG
GWAS signal (p<10-3) [2]. To determine whether the
significant TG GWAS SNPs or SNPs in high LD with
them in the ARHGAP9 and LST1 regions influence the
observed TG modules, we tested the GWAS SNPs in the
METSIM sample for correlation with the TG modules.
We did not observe a significant correlation between
rs11614506 in LD (r2=1) with the lead TG signal
(rs11613352) in the ARHGAP9 region (Additional file 7)
and the METSIM TG case/control brown module. How-
ever, in the LST1 region (Additional file 8), a SNP
rs486416 that represents an independent signal from the
lead TG GWAS signal, rs2247056, was significantly asso-
ciated with the brown TG module (P=0.005), while the
lead TG GWAS signal rs2247056 was not significantly
associated with the brown TG module (P>0.05). Add-
itionally, rs486416 is correlated with LST1 expression
(r=0.52, P=0.02), providing a possible mechanism under-
lying the SNP/TG module and TG module/serum TG
level associations. SNP rs486416 exhibited a p-value of
1.99x10-15 for TGs in the previous metaGWAS [2], thus
further suggesting LST1 as one of the underlining genes





T, ARHGAP30, FERMT3, RNASET2, SELPG < 10-7
engene and gene expression.
e Finnish Twin module, and the yellow Mexican module. P-values were
ng the module membership criteria and observing the number of overlaps
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We investigated whether human adipose transcript net-
works are correlated with serum TG levels across popu-
lations to identify novel TG-associated genes for future
targeted sequencing and functional studies. Using
WGCNA, we discovered that there are gene co-
expression networks in human adipose tissue signifi-
cantly correlated with serum TGs and highly conserved
across populations. The vast majority (93.5%) of the
genes in the Mexican TG network module overlapped
with the genes in the Finnish twin TG network module.
Furthermore, the module membership of the genes
shared between the Finnish and Mexican TG modules
significantly correlate with each other (r=0.67,
P=1.56x10-16). We also observed a significant overlap
with 34 genes shared across the TG modules of all three
sets of samples robust enough to be detected using two
different gene expression approaches, microarrays and
RNAseq. These 34 TG-associated genes identified in
WGCNA also significantly overlap with the top 500
most differentially expressed genes in all three sets of
samples (P<10-7 for the overlap), further validating the
WGCNA approach. The gene co-expression network
data of three independent sets of samples from Finnish
and Mexican populations provide strong evidence that
the 34 shared genes are involved in TG regulation in
both Finns and Mexicans, and probably other popula-
tions as well. Furthermore, the fact that the TG associa-
tions remain when BMI is used as a covariate in
stepwise regression provides evidence that the TG mod-
ule associations are not due to differences in adiposity
between the subjects. However, inferences about caus-
ation based on the WGCNA method must be supported
by both biological arguments and statistically significant
associations. We also recognize that some of the 34
genes may be reactive rather than causal. Taking into ac-
count these limitations, future targeted sequencing and
functional studies are warranted.
The strength of module membership also significantly
overlaps in all three TG modules. Seven of the 34 genes
with high module membership were observed as hub
genes, acting as key drivers of three TG modules (P<10-7
for the overlap, Table 3), spanning three sets of samples
and two gene expression platforms. This finding impli-
cates these seven genes in TG regulation, although add-
itional experimentation is necessary to search for a
specific molecular role they play in regulating TGs. Fur-
ther studies are also warranted to determine whether the
same 34 genes implicated are associated with TGs stored
in adipose tissue, because adipose TG values were not
available for our sets of samples. Two of the 34 genes
(ARHGAP9 and LST1) are located within 500 kb of a
significant TG metaGWAS signal, while seven other
genes lie near a suggestive TG GWAS signal [2].Teslovich and coworkers, however, suggest different re-
gional gene candidates associated with each of these two
TG GWAS signals (i.e. HLA-B and LRP1) [2]. In the
LRP1 region, ARHGAP9 identified in our study is
located nearer the actual GWAS SNP than LRP1, and in
the HLA region there were several non-redundant, sig-
nificantly associated SNPs not in LD [2], one of which is
located next to LST1, making LST1 a likely second hit
for the region.
Determining whether ARHGAP9 or LST1 expression
quantitative trait loci (eQTLs) are driving the TG-
associated WGCNA modules may reveal a novel mech-
anism of TG regulation. The recent metaGWAS study
[2] reports that none of the lead TG-associated GWAS
SNPs near HLA and LRP1 were cis-eQTLs in adipose
tissue. However, significant non-redundant regional
SNPs that are not in LD with the lead SNP were not
tested in this previous study [2]. Therefore, untested sig-
nificant regional TG-associated GWAS SNPs may act as
cis-eQTLs in adipose tissue, and they should thus be fur-
ther explored. Our analysis demonstrate that a signifi-
cant TG GWAS SNP rs486416 in the HLA/LST1 region
[2] is driving the adipose co-expression network asso-
ciated with TGs in the METSIM TG case/control study
sample by influencing LST1 expression, thus providing a
novel mechanism underlying the TG metaGWAS signal
in the HLA/LST1 region. The ARHGAP9 region
(±500kb) had only one significant TG GWAS signal [2]
that was not significantly correlated with the brown TG
module in METSIM TG cases/controls, in accordance
with the previous cis-eQTL study [2]. We also discov-
ered that 11 of the 34 genes found in all three TG mod-
ules show prior evidence of involvement in obesity, type
2 diabetes, or CHD (Additional file 6). The remaining 23
genes present novel TG candidates for future targeted
sequencing and functional studies.Conclusions
Our cross-ethnic network analysis provides evidence
that adipose gene co-expression networks correlated
with serum TG levels are significantly conserved across
two populations, the Mexicans and Finns. Within the
WGCNA networks, 34 genes significantly overlapped
and seven of them (ARHGAP30, CCR1, CXCL16,
FERMT3, HCST, RNASET2, SELPG) displayed strong
module membership in all three sets of samples, impli-
cating them as the key candidates for TG regulation in
human adipose tissue.Methods
The study design was approved by the ethics committees
of the participating centers and all subjects gave a writ-
ten informed consent.
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Finnish twin cohort
A total of 53 Finnish individuals (26 monozygotic twin
pairs concordant and discordant for BMI and one single
co-twin) were recruited for surgical abdominal subcuta-
neous fat biopsies at the Helsinki University Hospital,
Finland [18]. RNA was extracted and gene expression
was measured using Affymetrix U133 Plus 2.0 gene
chips, according to the manufacturer’s instructions and
as described previously [18]. To ensure that each probe
is expressed above background, gene expression probes
that were expressed in at least half of the 53 samples
were included in the analysis. To prevent potentially
confounding factors influencing expression values, gene
expression values were corrected for age, sex, and twin
relatedness using the Microarray Quality Control Pipe-
line as described previously [10], resulting in 16,048
probes passing quality control. Lipid values were mea-
sured using enzymatic methods from Roche Diagnostic
Hitachi tools, as described previously [18]. LogTG and
BMI were corrected for significant covariates using step-
wise regression. LogTG covariates tested included age,
sex, disconcordant twin BMI status, and BMI. BMI cov-
ariates tested included age, sex, disconcordant twin BMI
status, and TG.
Mexican TG cases/controls
Seventy Mexican high TG cases and low TG controls
were recruited at the Instituto Nacional de Ciencias
Medicas y Nutricion, Salvador Zubiran, Mexico City,
Mexico for surgical abdominal subcutaneous fat biopsies
[10]. RNA was purified from subcutaneous adipose tis-
sue and the microarray data was normalized using the
Microarray Quality Control Pipeline, as previously
described [10], resulting in 14,942 probes passing quality
control. TG values were measured using enzymatic
methods (SERA-PAK), as previously described [19].
Gene expression values were corrected for age, sex, and
kinship, and lipid values were measured as described
previously [19]. LogTG and BMI were corrected for sig-
nificant covariates using stepwise regression. LogTG
covariates tested included age, sex, TG case/control sta-
tus, and BMI. BMI covariates tested included age, sex,
TG case/control status, and TG.
METSIM Cohort
The Finnish population-based cohort, METSIM (METa-
bolic Syndrome In Men) was collected at the University
of Kuopio, Kuopio, Finland as described previously [20].
The METSIM cohort is a randomly ascertained sample
of 10,197 men aged 45–70 from Kuopio, Eastern Finland
[20]. Twenty METSIM subjects with high TG (3.57 ±
1.69 mg/dl) or low TG (0.56 ± 0.06 mg/dl) values who
were not on lipid lowering medication were selected forRNA sequencing. RNA was extracted from subcutane-
ous adipose tissue of the 20 METSIM subjects, and lipid
measurements were performed using nuclear magnetic
resonance (NMR), as described previously [21,22].
LogTG and BMI were corrected for significant covari-
ates using stepwise regression. LogTG covariates tested
included age, sex, TG case/control status, and BMI. BMI
covariates tested included age, sex, TG case/control sta-
tus, and TG.
RNA Sequencing
We prepared the samples for RNA-sequencing using the
Illumina mRNA-Sequencing kit, following the manufac-
turer’s instructions. Single-end, 50bp reads were pro-
duced using Illumina HiSeq2000 sequencing platform.
Reads passing Illumina’s default quality control were
aligned to the ENSEMBL v62 reference genome using
the default options of TopHat v1.3.3 [23,24], a package
for aligning RNAseq data to a reference genome. The
expression level of a gene was determined with the Cuf-
flinks software package [25-27] using the TopHat output
to compute gene expression values as FPKM (Fragments
per kilobase of exon per million mapped reads). FPKM
is calculated by counting the number of reads spanning
a gene and dividing by the length of the gene (in kilo-
bases) and the number of reads in a lane that map to the
genome (in millions). FPKM accounts for the variability
in mapped reads seen across sequencing lanes and gene
length to improve the accuracy of the gene expression
value. On average, 100,225,314 reads mapped to 14,223
RefSeq genes after the QC was performed.
Weighted gene co-expression network analysis (WGCNA)
We used WGCNA, which is a systems biology analysis
method, to identify TG-associated co-expression mod-
ules and their key constituents [11,12,28]. WGCNA
starts from the level of thousands of genes, identifies
modules of co-expressed genes, and relates these mod-
ules to clinical variables and gene ontology information.
Because gene modules may correspond to biological
pathways, focusing the analysis on modules (and their
highly connected intramodular hub genes) amounts to a
biologically meaningful data reduction scheme. WGCNA
is implemented in the R software package. Briefly,
WGCNA uses a network distance coupled with hier-
archical clustering and dynamic tree cutting to define
modules as branches of a cluster tree. Modules (clusters)
are defined in an unbiased fashion and initially denoted
by colors. Grey denotes background genes outside of
modules. The highly correlated module genes of a given
module are represented and summarized by their first
principal component (which is referred to as the module
eigengene). The module eigengenes are used to define
measures of module membership which quantify how
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membership (aka kME) is defined as the correlation be-
tween a gene expression value and the module eigengene
(the average module expression value for an individual).
Module membership measures allow one to annotate all
genes on the array and to screen for disease related
intramodular hub genes [29]. As described below, we
use functional enrichment analysis with regard to known
gene ontologies to understand the biological significance
of module genes and to identify intramodular hub genes
as candidate driver genes. WGCNA was applied separ-
ately to each of the three gene expression datasets:
Finnish twins, Mexican TG case/control and METSIM.
UCSC genes expressed in METSIM samples (n= 13,822
genes) were inputted into WGCNA, while all expressed
probes in the Mexican samples (14,942 probes) and
Finnish twin samples (16,048 probes) were used to form
the WGCNA networks. We utilized the blockwiseMo-
dules R function of WGCNA [11,12] to determine co-
expression networks formed in adipose tissue in each of
the three populations. This approach has been used in
several previous systems genetic applications, e.g. in
Plaisier at al. [10]. The module colors are determined by
the number of genes/probes within the module. There-
fore, comparing the color labels observed between the 3
sets of samples does not indicate whether the modules
are related (i.e. the yellow module in the Mexican study
sample is not comparable to the yellow module in the
Finnish Twin study sample). When evaluating the sig-
nificance of the module correlations of WGCNA, we
corrected the p-values for the number of modules and
the number of tested phenotypic traits.
Module preservation
Our module preservation analysis is based on a permu-
tation test implemented in the modulePreservation R
function [30]. The modulePreservation function imple-
ments a permutation test involving several powerful net-
work based statistics for evaluating module preservation.
These statistics are summarized into the composite pres-
ervation called Zsummary. For each module in the first
data set (referred to as reference data), the function cal-
culates the Zsummary statistic in the second data set
(referred to as test data). For a given module, Zsum-
mary>10 indicates strong evidence for preservation in
the test data set. Zsummary < 2 indicates no evidence of
module preservation. An advantage of the preservation
Z statistic is that it makes few assumptions regarding
module definition and module properties.
Cross-tabulation based tests of module overlap
To merge expression data sets measured on different
platforms, we used the collapseRows R function [29].
Briefly, this method first collapses multiple probes bygene symbol which allows one to merge the data by gene
symbol [31]. The microarray probe with the greatest
variance between samples was used to represent a given
gene in the Mexican and Finnish twin samples.
To determine the relationship between two module
assignments in two different data sets, we used standard
cross-tabulation based methods (Fisher’s Exact test). We
placed each expressed gene into a 2x2 categorical con-
tingency table based on whether the gene was part of a
TG-associated module in the two study samples tested.
To determine the likelihood of overlapping modules,
genes were randomly selected using the criteria specified
in Table 3 and an empirical p-value was calculated after
10 million trials to accurately model the likelihood of
these results occurring by chance. For the empirical p-
value of the overlap between the three modules, we con-
sidered 10 billion trials sufficient as it would allow us to
reach a p-value level of 10-10. We utilized the GO BP
FAT function of DAVID to determine gene ontology bio-
logical processes enriched in the genes overlapping in all
3 TG modules [16,17]. Genes expressed in each dataset
were used as the background measurement for DAVID.
Gene expression overlap in TG cases and controls
In addition to the WGCNA analysis that was performed
using quantitative TG values, we also performed differ-
ential gene expression analysis using a qualitative TG ap-
proach. In METSIM, Mexican, and Finnish twin sets of
samples, each individual was labeled as a case or control
using 1.5 mmol/L cut off, which represents the average
fasting serum TG values for European origin male adults
reported by the American Heart Association [32]. We
used a two-tailed Fisher’s exact test to determine the sig-
nificance of the TG module overlap. Six of 53 Finnish
twins had TG values > 1.5 mmol/L, 10 of 20 METSIM
samples had TG values > 1.5 mmol/L, and 44 of the
Mexican TG case/controls had TG values > 1.5 mmol/L.
Gene expression - TG correlations
In the three sets of samples we compared the percen-
tages of genes that were correlated with TGs in each
module. For these comparisons, correlation p-values
were calculated using Pearson correlation between gene
expression and quantitative TG values.
Additional file descriptions
The following additional data are available with the on-
line version of this paper. Additional data file 1 is a table
listing the clinical characteristics of the Finnish and
Mexican sets of samples. Additional data file 2 is a figure
of the WGCNA results in the Mexican study sample.
Additional file 3 is a figure of the WGCNA results
in the METSIM study sample. Additional file 4 is the
module preservation results for the Finnish twin and
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the significant DAVID gene enrichment results. Add-
itional file 6 is a table describing the relevance of the TG
module overlap genes to CHD-related traits. Additional
file 7 is a figure illustrating the GWAS results in the
ARHGAP9 region from a prior TG GWAS. Additional
file 8 is a figure illustrating the GWAS results in the
LST1 region from a prior TG GWAS. In the three sets
of samples we compared the percentages of genes that
were correlated with TGs in each module. For these
comparisons, correlation p-values were calculated using
Pearson correlation between gene expression and quan-
titative TG values.Additional files
Additional file 1: Clinical characteristics of the Finnish and Mexican
sets of samples. Additional data file 1 is a table listing the clinical
characteristics of the Finnish and Mexican sets of samples.
Additional file 2: The WGCNA results show that the yellow module
is associated with serum TG levels in the Mexican TG cases/controls.
Additional data file 2 is a figure of the WGCNA results in the Mexican sets
of samples.
Additional file 3: The WGCNA results indicate that the brown
module is associated with serum TG levels in the METSIM TG cases/
controls. Additional file 3 is a figure of the WGCNA results in the METSIM
sets of samples.
Additional file 4: The Finnish Twin WGCNA blue TG module is
moderately preserved in the METSIM TG case/control study sample.
Additional file 4 is the module preservation results for the Finnish twin
and Mexican sets of samples.
Additional file 5: The 34 genes found in the Finnish twin, METSIM,
and Mexican TG modules are enriched for immunity and
inflammation genes. Additional file 5 is a table of the significant DAVID
gene enrichment results.
Additional file 6: List of the 34 genes that overlap in all three
WGCNA triglyceride modules in the Finnish Twins, METSIM, and
Mexican sets of samples. Additional file 6 is a table describing the
relevance of the TG module overlap genes to CHD-related traits.
Additional file 7: The TG metaGWAS results in the ARHGAP9 region
(+/− 500kb) utilizing the publicly available data from Teslovich
et al. 2012. Additional file 7 is a figure illustrating the GWAS results in
the ARHGAP9 region from a prior TG GWAS.
Additional file 8: The TG metaGWAS results in the LST1 region
(+/− 500kb) utilizing the publicly available data from Teslovich
et al. 2010. Additional file 8 is a figure illustrating the GWAS results in
the LST1 region from a prior TG GWAS.Abbreviations
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